EMEA-002938-PIP01-20
Key facts
| Active substance |
Islatravir
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0407/2021
|
| PIP number |
EMEA-002938-PIP01-20
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Prevention of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe) Inc.
Tel. +33 180464738 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|